Stefan Bijmolt

Zoekresultaten

• 2021

  Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer

  PORTEC study group, Wortman, B. G., Astreinidou, E., Laman, M. S., van der Steen-Banasik, E. M., Lutgens, L. C. H. W., Westerveld, H., Koppe, F., Slot, A., van den Berg, H. A., Nowee, M. E., Bijmolt, S., Stam, T. C., Zwanenburg, A. G., Mens, J. W. M., Jürgenliemk-Schulz, I. M., Snyers, A., Gillham, C. M., Weidner, N. & Kommoss, S. & 4 anderen, Vandecasteele, K., Tomancova, V., Creutzberg, C. L. & Nout, R. A., feb.-2021, In: Radiotherapy and Oncology. 155, blz. 160-166 7 blz.

  Onderzoeksoutput › Academic › peer review

  Open Access

  Bestand

  • Quality Assurance 100%
  • Adjuvant Therapy 100%
  • Risk Profile 100%
  • Brachytherapy 100%
  • Endometrial Cancer 100%
  17 Citaten (Scopus)

  101 Downloads (Pure)
• 2020

  PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

  van den Heerik, A. S. V. M., Horeweg, N., Nout, R. A., Lutgens, L. C. H. W., van der Steen-Banasik, E. M., Westerveld, G. H., van den Berg, H. A., Slot, A., Koppe, F. L. A., Kommoss, S., Mens, J. W. M., Nowee, M. E., Bijmolt, S., Cibula, D., Stam, T. C., Jurgenliemk-Schulz, I. M., Snyers, A., Hamann, M., Zwanenburg, A. G. & Coen, V. L. M. A. & 10 anderen, Vandecasteele, K., Gillham, C., Chargari, C., Verhoeven-Adema, K. W., Putter, H., van den Hout, W. B., Wortman, B. G., Nijman, H. W., Bosse, T. & Creutzberg, C. L., dec.-2020, In: International Journal of Gynecological Cancer. 30, 12, blz. 2002-2007 6 blz.

  Onderzoeksoutput › Academic › peer review

  Open Access

  Bestand

  • Adjuvant Therapy 100%
  • Randomized Trial 100%
  • Intermediate Risk 100%
  • Endometrial Cancer 100%
  • Molecular Profile 100%
  155 Citaten (Scopus)

  160 Downloads (Pure)
• 2019

  Brachytherapy quality assurance in the PORTEC-4a trial for high-intermediate risk endometrial cancer

  Wortman, B., Astreinidou, E., Laman, M., Lutgens, L., Van der Steen-Banasik, E., Slot, A., Westerveld, H., De Winter, K., Van den Berg, H., Bloemers, M., Stam, T., Mens, J., Zwanenburg, L., Bijmolt, S., Juergenliemk-Schulz, I., Snyers, A., Creutzberg, C. & Nout, R., apr.-2019, In: Radiotherapy and Oncology. 133, blz. S198-S199 2 blz.

  Onderzoeksoutput › Academic

  Open Access

  Bestand
  66 Downloads (Pure)

• Feasibility planning study for hypofractionated salvage prostate bed radiotherapy

  Koopman, L., Van der Neut, S., Roos, C., Hammer, C., Vanhauten, H., Bijmolt, S., Van den Bergh, A., Lagendijk, J., Both, S., Brouwer, C. & Al-Uwini, S., apr.-2019, In: Radiotherapy and Oncology. 133, blz. S1206-S1206 1 blz.

  Onderzoeksoutput › Academic

  Open Access

  Bestand
  75 Downloads (Pure)

• Feasibility study of extreme hypofractionated proton treatment planning for prostate cancer

  Klinker, P., Brouwer, C., Roos, C., Hammer, C., Vanhauten, H., Bijmolt, S., Langendijk, J., Both, S., Van den Bergh, A. & Al-Uwini, S., apr.-2019, In: Radiotherapy and Oncology. 133, blz. S994-S995 2 blz.

  Onderzoeksoutput › Academic

  Open Access
• 2018

  Long term toxicity after radiotherapy for prostate cancer: NTCP models for rectal toxicity.

  Van Vreeswijk, N. L., Hammer, C., Van den Bergh, A. C. M., Vanhauten, H. A. M., Bijmolt, S., Langendijk, J. A. & Aluwini, S., apr.-2018, blz. S332. 1 blz.

  Onderzoeksoutput › Academic

  Open Access

  Bestand
  184 Downloads (Pure)